UpStacked is the All-in-One centralized operations platform that crushes SLA requirements to increase profitability and reduce OPEX. Purpose-built for internal IT and MSPs to operate SMBs and Enterprises. With user experience in mind, UpStacked drives complex to zero-touch, through automation and machine learning. UpStacked at a Glance: - All-in-One Centralized Platform - Enterprise onboarding in minutes - Third-Party integrations - Zero-Touch - Simplified License Management - Real-Time On-Demand Reporting - Real-Time Topology Based Correlation - Real-Time Event-Based Correlation - Built-in Role Based Access Control - Natively Multi-Tenant - Multi-Vendor - ITIL

Speak Norsk is an ambitious team that started with one goal in mind – to make expats fluent in Norwegian! We are passionate about language-learning and bringing to Norway a new, innovative way of teaching Norwegian. Since the beginning, we have been known for our interactive conversation-focused classes, own-written books, and something that it´s not quite common for other schools – a personal approach and a customized offer for each one of our students. Meet our passionate and united team of Speak Norsk school!

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

LifeTools AS develops digital tools for people with complex needs within the fields of communication, cognition, and challenged behavior. We put the user first and develop dynamic systems with high flexibility based on the unique user's needs. The network around the user will have digital tools to observe, build and publish expressions, routines, and activities into our systems, and use this information back into the interaction with the user. This gives a better foundation in communication and helps increase the quality of life for the user. Our philosophy is to use "everyday technology" such as tablets/phones and cloud-based solutions and develop highly intuitive and dynamic tools for the network. Users (people with special and complex needs) therefore do not need to acquire skills or knowledge in order to use our systems. This makes it easier for those who have great cognitive challenges to make use of our technological solutions.

Nordic Electrofuel offers a solution for the rapid transition from fossil to renewable electrical energy for all transport sectors. It is based on the conversion of renewable electric energy into liquid electro-fuels that can be as easily transported, stored, and used as conventional fossil hydrocarbons. It also provides a good solution to distribute and store stranded electrical energy. PTL (Power To Liquid) has been considered too expensive, but with the low electricity price in Norway and new efficient processing and upgrading solutions, it has become commercially feasible. Electrification of transportation is required to avoid catastrophic climate change. Battery- or cable-electric solutions are not feasible for transport like aviation and long-distance marine transport. Liquid energy carriers such as biofuels are desperately needed but limited. The fuel is free of sulfur and can therefore be used maritime industry as a fuel after 2022. The fuel emits much fewer particles and aromatics than conventional fossil fuel, so it also solves the local pollution problem. Competitive advantages: • Norway’s low electricity price from hydro and lately also wind power. • 20 - 30 % lower electricity consumption than with existing technology • Lower production price than advanced biofuels • Agreements in place for a site at Herøya, which has all utilities (cooling water, cheap renewable electricity, etc.) and processing expertise available. • About the same source to shaft efficiency as hydrogen, but with much lower total CAPEX due to no investment in distribution systems and engines.

Vi tør å tenke nytt i en bransje som er preget av umoderne arbeidsformer, og kombinerer tung juridisk kompetanse med markedsledende teknologi. LIGL ble startet for å utfordre den konservative advokatbransjen, og bygger på tre grunnleggende prinsipper, kompetanse, kultur og teknologi – vårt DNA. Gjennom innovativ bruk av teknologi, en moderne forretningsmodell og et unikt arbeidsmiljø, vil vi skape et reelt, effektivt og eksklusivt alternativ til de største advokatfirmaene i Norge. Vi vet at dette vil og må ta tid, men vi vet også at det er denne veien bransjen vil utvikle seg – og vi ønsker å være i forkant. LIGL består av topp kvalifiserte forretningsadvokater med lang fartstid, solid faglig ekspertise og entusiasme for den jobben de gjør. Flere av firmaets advokater kommer fra ledende partnerstillinger i landets største advokatfirmaer. Kundene våre er norske og internasjonale virksomheter. Vi bistår alt fra gründervirksomheter i oppstart, til store selskaper med en lang historie å se tilbake på. Vi tar også oppdrag for privatpersoner innenfor utvalgte rettsområder. Firmaet leverer advokattjenester innen følgende fagområder: - Corporate, strategisk selskapsrettslig rådgivning - Rekonstruksjon & insolvens - Immaterialrett & teknologi - Fast eiendom - Skatt - Tvisteløsning Firmaets advokater er dyktige tverrfaglige forretningsadvokater, og firmaet tar derfor også oppdrag innenfor andre fagområder som naturlig leveres av et kompetent forretningsadvokatfirma, som arbeidsrett, kontraktsrett, entreprise etc.

We start our project in 2017. We develop and offer to the market ecological & sustainable fertilizers made by mineral and organic nature. We cultivate a unique product and engage experience and innovation. By offering a quality product with added value to our customers, we help make a cost-effective solution for horticulture and agriculture.  We are happy to be engaged in the optimization of performance for allied businesses and private customers.

Da jeg brenner for startups - strekker jeg meg langt hvis det er noe jeg kan hjelpe med - forutsetter at: 1. Jeg liker ideen. 2. Jeg liker menneskene.Fått noen spørsmål om jeg vil være co-founder. Men så lenge jeg har min egen startup ide så prioriterer jeg jobbe med egne ting. Men som sagt -  jeg kan hjelpe med noe så er det bare å spørre.

Good For Me AS er et ambisiøst selskap som ble etablert i 2013 og har siden oppstart vært en pionér i bransjen. Vår visjon er å være en ledende aktør innen kosttilskudd av høy kvalitet, samt dele kunnskap og inspirasjon som bidrar til å gi folk et bedre og sunnere liv, samtidig som vi tar vare på planeten vår. Alle produktene våre er 100% veganske og det er et verdivalg fra vår side: vi ønsker ikke at produktene våre skal inneholde ingredienser derivert fra dyr eller som er testet på dyr. Produktene selges i vår egen nettbutikk og gjennom over 1000 forhandlere i Norge, primært Vitus Apotek, Ditt Apotek og Apotek 1. Innovasjon er viktig for oss og vi jobber kontinuerlig med produkt- og konseptutvikling, nye markedsføringsmetoder og ny teknologi. Etter å ha inntatt en sterk posisjon oss i det norske markedet, satser vi nå også i Europa.

Unaas Cycling ble etablert i 2008. Vi har fokusert oss på utvikling av hi-end hjulsett, samt salg og service på konkurranssykler innen alle sykkelgrener. Nå deler vi utviklingen av våre hjul og vårt verksted og etablerer Maridalen sykkelverksted AS. Dette er en service-senter for din sykkel. Her kan du få service på sykkel, samt kjøpe rimelige sykkeldeler. I tillegg selger vi hi-end sykkelmerket BMC og Unaas hjulsett.

At Viva Labs, we are building the next generation of smart homes. Homes that use technology in unobtrusive ways to make life easier for families.We want to work with people who are passionate about user experience and software quality, and who are excited about the connected home. We are a tech startup with head offices in Oslo, but with team members spread around the world.

Arctic Innovative develop innovative applications for the future. Our goal is to make excisting sollutions better, or creating new innovative sollutions for a better tomorrow. We are a start up company established early 2016, and are based in Ålesund Norway. We seek new promising  experienced developers to join our development team.   We are working witn several new exciting applications, and the application we work most with nowdays is the innovative +Drone app that we launced 3 months ago worldwide.   If you are a experienxed developer, and want to be part of a promising start up, and like to join us on this exciting journey feel free to contact us.   post@arcticinnovativesolutions.no

Velkommen til OctoPro! Vi jobber for at våre brukere skal bli mestere på produktivitet og få frigjort tid til andre ting de ønsker å bruke den på. Det gjør vi med vår native app for Mac som måler produktiviteten din og bidrar med tips til hvordan du kan forbedre arbeidet ditt. Din personlige assistent kan du si. Vi er nylig startet, men har en forykende fart og lanserte vårt første MVP på kun 3 uker. Vi ser etter flere flinke folk som vil bli en del av teamet og ta OctoPro til resten av verden. Er du en av dem? Send oss gjerne en melding!

The global shortage of developers may reach 85.2 million by 2030. Through the current downturn, companies will need to do more with less. They risk losing $8.5 trillion in annual revenue because of this problem. Companies can increase developer velocity through: - Empowerment - Anticipating needs - Focussing on business problems - Minimizing barriers to productivity The Dolittle platform allows developers to retrofit existing enterprise applications in a low code environment, quickly and iteratively. We reduce barriers to productivity by making data locked in enterprise systems available in real time. We empower developers by making it easy to connect, compose and build applications. Our product allows developers to focus on the business problem; enabling new revenue streams.